Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

The cytoprotective protein C pathway.

Mosnier LO, Zlokovic BV, Griffin JH.

Blood. 2007 Apr 15;109(8):3161-72. Epub 2006 Nov 16. Review.

2.

Activated protein C.

Griffin JH, Fernández JA, Gale AJ, Mosnier LO.

J Thromb Haemost. 2007 Jul;5 Suppl 1:73-80. Review.

3.

Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.

Mosnier LO, Gale AJ, Yegneswaran S, Griffin JH.

Blood. 2004 Sep 15;104(6):1740-4. Epub 2004 Jun 3.

5.

Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.

Cheng T, Liu D, Griffin JH, Fernández JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV.

Nat Med. 2003 Mar;9(3):338-42. Epub 2003 Feb 3.

PMID:
12563316
6.

Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.

Yang L, Bae JS, Manithody C, Rezaie AR.

J Biol Chem. 2007 Aug 31;282(35):25493-500. Epub 2007 Jun 19.

7.

Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells.

Cabello-Gutiérrez C, Manjarrez-Zavala ME, Huerta-Zepeda A, Cime-Castillo J, Monroy-Martínez V, Correa BB, Ruiz-Ordaz BH.

Thromb Haemost. 2009 May;101(5):916-28.

PMID:
19404546
8.

Activated protein C: a promising drug with multiple effects?

Loubele ST, Spronk HM, Ten Cate H.

Mini Rev Med Chem. 2009 May;9(5):620-6. Review.

PMID:
19456292
9.

Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities.

Mosnier LO, Griffin JH.

Front Biosci. 2006 Sep 1;11:2381-99. Review.

PMID:
16720321
10.

Protein C anticoagulant and cytoprotective pathways.

Griffin JH, Zlokovic BV, Mosnier LO.

Int J Hematol. 2012 Apr;95(4):333-45. doi: 10.1007/s12185-012-1059-0. Epub 2012 Apr 5. Review.

11.

Activated protein C and ischemic stroke.

Griffin JH, Fernández JA, Liu D, Cheng T, Guo H, Zlokovic BV.

Crit Care Med. 2004 May;32(5 Suppl):S247-53. Review.

PMID:
15118526
12.
14.

Protein C and its inhibitor in malignancy.

Suzuki K, Hayashi T.

Semin Thromb Hemost. 2007 Oct;33(7):667-72. Review.

PMID:
18000793
15.

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID:
11445734
16.

Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.

Riewald M, Petrovan RJ, Donner A, Ruf W.

J Endotoxin Res. 2003;9(5):317-21.

PMID:
14577849
17.

New therapeutic applications for the anticoagulant, activated protein C.

Jackson C, Whitmont K, Tritton S, March L, Sambrook P, Xue M.

Expert Opin Biol Ther. 2008 Aug;8(8):1109-22. doi: 10.1517/14712598.8.8.1109 . Review.

PMID:
18613763
18.
19.

Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.

Dahlbäck B, Villoutreix BO.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1311-20. Epub 2005 Apr 28. Review.

20.

Endogenous protein C activation in patients with severe sepsis.

Liaw PC.

Crit Care Med. 2004 May;32(5 Suppl):S214-8. Review.

PMID:
15118520

Supplemental Content

Support Center